Literature DB >> 25243251

Dalbavancin or oritavancin for skin infections.

G Ralph Corey, Hai Jiang, Greg Moeck.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25243251     DOI: 10.1056/NEJMc1407925

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  5 in total

1.  Do Patients with Cellulitis Need to be Hospitalized? A Systematic Review and Meta-analysis of Mortality Rates of Inpatients with Cellulitis.

Authors:  Craig G Gunderson; Benjamin M Cherry; Ann Fisher
Journal:  J Gen Intern Med       Date:  2018-07-18       Impact factor: 5.128

2.  Repurposing auranofin for the treatment of cutaneous staphylococcal infections.

Authors:  Shankar Thangamani; Haroon Mohammad; Mostafa F N Abushahba; Tiago J P Sobreira; Mohamed N Seleem
Journal:  Int J Antimicrob Agents       Date:  2016-01-23       Impact factor: 5.283

3.  Treatment Duration and Associated Outcomes for Skin and Soft Tissue Infections in Patients With Obesity or Heart Failure.

Authors:  Claudia Ihm; Jesse D Sutton; Tristan T Timbrook; Emily S Spivak
Journal:  Open Forum Infect Dis       Date:  2019-05-07       Impact factor: 3.835

4.  Repurposing ebselen for treatment of multidrug-resistant staphylococcal infections.

Authors:  Shankar Thangamani; Waleed Younis; Mohamed N Seleem
Journal:  Sci Rep       Date:  2015-06-26       Impact factor: 4.379

Review 5.  Novel antibiotics: are we still in the pre-post-antibiotic era?

Authors:  R Draenert; U Seybold; E Grützner; J R Bogner
Journal:  Infection       Date:  2015-02-21       Impact factor: 3.553

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.